Stay updated on VIP152 Dose Escalation Study in Advanced Cancer Clinical Trial

Sign up to get notified when there's something new on the VIP152 Dose Escalation Study in Advanced Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the VIP152 Dose Escalation Study in Advanced Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Difference
    2%
    Check dated 2025-05-08T14:15:10.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    2%
    Check dated 2025-05-01T06:33:55.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    2%
    Check dated 2025-04-24T01:52:52.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed study descriptions and eligibility criteria for a clinical trial involving VIP152, while adding a new EudraCT number and a revision number.
    Difference
    14%
    Check dated 2025-04-16T20:53:05.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.7%
    Check dated 2025-04-09T16:00:31.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to include information on Ovarian Cancer and Ovarian Epithelial Cancer, while removing references to Lymphosarcoma and Renal Cell Carcinoma. Additionally, the revision number has been updated from v2.14.2 to v2.14.3.
    Difference
    2%
    Check dated 2025-04-02T00:23:50.000Z thumbnail image

Stay in the know with updates to VIP152 Dose Escalation Study in Advanced Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the VIP152 Dose Escalation Study in Advanced Cancer Clinical Trial page.